Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronomic Vinorelbine Maintenance in Advanced NSCLC (MA.NI.LA.)
NCT02176369Phase 2Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Feb 2013
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vinorelbine in non-small cell lung cancer (NSCLC), sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Started Feb 2013; status: completed.
02
Drugs
vinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02176369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02176369.